← Back to graph

Biomarker

lipoprotein(a) diurnal AM

Selected indexed studies

Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing. (Am J Cardiol, 1998) [PMID:9915659]

_Worker-drafted node — pending editorial review._

Connections

lipoprotein(a) diurnal AM is a risk factor for

Cardiovascular DiseaseDisease

Sources

Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing. (1998) pubmed

Local graph